Diabetic Foot Ulcer Market Growth Report | Size & Share 2030
[研究报告] 糖尿病足溃疡市场规模预计将从 2022 年的 74.706 亿美元增长到 2030 年的 122.4277 亿美元;预计 2022 年至 2030 年的复合年增长率为 6.4%。
市场洞察和分析师观点:
糖尿病足溃疡是一种慢性伤口,经常导致并发症,对外科医生处理此类伤口提出了挑战。糖尿病足溃疡会导致 1 型或 2 型糖尿病患者因神经病变和/或血管并发症导致足部全层皮肤缺失。使用胰岛素的糖尿病患者患足溃疡的风险更高。推动糖尿病足溃疡市场增长的关键因素包括糖尿病和相关慢性伤口的高患病率以及老年人口的激增。然而,伤口管理的高成本阻碍了市场的增长。
增长动力和限制因素:
糖尿病患者容易受伤,愈合过程通常较长。根据愈合时间,伤口可分为急性和慢性。糖尿病是一种危及生命的慢性疾病,没有功能性治愈方法。糖尿病可导致身体不同部位出现各种并发症,并增加过早死亡的总体风险。根据国际糖尿病联合会 (IDF) 的数据,2021 年全球约有 5.37 亿成年人患有糖尿病。预计到 2030 年,这一数字将增加到 6.43 亿,到 2045 年将增加到 7.83 亿。糖尿病患者足部的血管和神经容易受损,导致麻木。因此,糖尿病患者患糖尿病足溃疡的几率更高。根据 2021 年美国国家生物技术信息中心 (NCBI) 发表的一项研究,患糖尿病足溃疡的风险在 19% 至 34% 之间。患者在康复后 1 年内复发率约为 40%,3 年内复发率约为 60%,5 年内复发率约为 65%。根据同一项研究,有报道称 50-60% 的溃疡会发展为感染,这是损害糖尿病足的主要原因。因此,全球对糖尿病足溃疡治疗的需求正在上升,从而推动了市场的增长。
老年人口激增进一步推动了糖尿病足溃疡市场的发展。与年龄相关的糖尿病在全球很常见。胰岛素分泌不足会随着年龄的增长而发展,由于身体成分的变化和肌肉减少症,胰岛素抵抗会增加。根据内分泌学会的数据,估计 33% 的 65 岁或以上成年人患有糖尿病。此外,人群患糖尿病相关并发症的风险更高。根据 2019 年全球老龄化调查,到 2025 年,65 岁或以上人口的数量将从 2019 年的 11 分之一显着增加到 1/6。根据美国人口普查局的数据,到 2060 年,65 岁及以上的美国人数量预计将从 2016 年的 4600 万增加一倍至 9800 多万,老年人口在全球人口中的比例将从 15% 增加到同期的约 24%。此外,到 2050 年,全球大多数地区的老龄化速度(即 60 岁及以上人口)将接近四分之一或更多。老年人患糖尿病的可能性更大,预计还会患上糖尿病足溃疡和慢性伤口,严重影响生活质量。因此,随着老龄人口的增加,未来几年对高级糖尿病足溃疡治疗的需求将继续增加。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
糖尿病足溃疡市场:
Diabetic Foot Ulcer Market: Strategic Insights
Diabetic Foot Ulcer Market
-
CAGR (2022 - 2030)
6.4%
-
Market Size 2022
US$ 7.47 Billion
-
Market Size 2030
US$ 12.24 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Convatec Group Plc
- 3M Co
- Coloplast AS
- Smith Nephew Plc
- B Braun SE
- Molnlycke Health Care AB
- MiMedx Group Inc
- URGO MEDICAL Australia Pty Ltd
- Medline Industries LP
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
溃疡类型(神经性溃疡、缺血性溃疡和神经缺血性溃疡)
治疗类型(高级伤口护理敷料、生物制剂和治疗设备)
感染严重程度(中度、轻度和重度)
最终用户(医院、门诊手术中心和家庭护理)
Diabetic Foot Ulcer Market: Strategic Insights
-
CAGR (2022 - 2030)6.4% -
Market Size 2022
US$ 7.47 Billion -
Market Size 2030
US$ 12.24 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Convatec Group Plc
- 3M Co
- Coloplast AS
- Smith Nephew Plc
- B Braun SE
- Molnlycke Health Care AB
- MiMedx Group Inc
- URGO MEDICAL Australia Pty Ltd
- Medline Industries LP
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2022 - 2030 年)6.4%- 2022 年市场规模
74.7 亿美元 - 2030 年市场规模
122.4 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 康威泰克集团
- 3M 公司
- 康乐保公司
- 史密斯和侄子公司
- B. Braun SE
- 莫林利克医疗保健公司
- MiMedx集团公司
- 优格医疗澳大利亚有限公司
- 美德林工业公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 神经性溃疡
- 缺血性溃疡
- 神经缺血性溃疡
- 高级伤口护理敷料
- 生物制剂
- 治疗装置
- 缓和
- 温和的
- 严重
- 医院
- 门诊手术中心
- 家庭护理
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
据 Integra LifeSciences Corporation 称,糖尿病足溃疡的治疗费用对美国医疗体系造成了沉重的负担,每年高达 90 亿至 130 亿美元。根据哈德斯菲尔德大学发布的数据,在英国,治疗医疗相关感染 (HCAI),尤其是手术部位感染 (SSI) 的费用估计为 10 亿英镑(约合 12.6 亿美元)。此外,据澳大利亚糖尿病协会称,糖尿病相关截肢费用接近 23,555 美元,术后每年还需额外花费 6,065 美元。在五年内,糖尿病相关截肢费用将近 50,000 美元,这还不包括社会成本。伤口面积和手术的复杂程度也决定了治疗费用。
在印度、中国和韩国等亚太国家,糖尿病足溃疡治疗费用也很高。根据爱思唯尔 2022 年发表的一项研究,在中国,糖尿病足溃疡治疗费用约为每位患者 21,372 美元,包括截肢、住院和医疗费用。同样,在印度,费用约为每位患者 19,599 美元,包括抗生素、神经性药物、敷料、胶原支架、生长因子、负压伤口治疗和手术。因此,尽管可以获得报销,但先进的伤口护理治疗费用高昂是制约全球糖尿病足溃疡市场增长的关键因素。
报告细分和范围:
“全球糖尿病足溃疡市场”根据溃疡类型、治疗类型、感染严重程度和最终用户进行细分。全球糖尿病足溃疡市场按治疗类型细分为高级伤口护理敷料、生物制剂和治疗设备。根据溃疡类型,市场细分为神经性溃疡、缺血性溃疡和神经缺血性溃疡。全球糖尿病足溃疡市场按感染严重程度细分为中度、轻度和重度。全球糖尿病足溃疡市场按最终用户细分为门诊手术中心、医院和家庭护理。
根据地理位置,糖尿病足溃疡市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
节段分析:
根据溃疡类型,全球糖尿病足溃疡市场分为神经性溃疡、缺血性溃疡和神经缺血性溃疡。神经缺血性溃疡细分市场在 2022 年占据最大市场份额,预计在 2022 年至 2030 年期间将实现最高复合年增长率。神经缺血主要导致足部、脚趾和背部边缘出现溃疡,尤其是在穿不合脚的鞋子的人的压力部位。此类伤口的治疗相对复杂。伤口需要及时护理、合适的鞋子、卸下、敷料和感染治疗。神经缺血性溃疡是最常见的糖尿病足溃疡 (DFU)。
全球糖尿病足溃疡市场按治疗类型细分为高级伤口护理敷料、生物制剂和治疗设备。高级伤口护理敷料部分在 2022 年占据最大市场份额。生物制剂部分预计在 2022-2030 年期间实现最高复合年增长率。全球糖尿病足溃疡市场按感染严重程度分为中度、轻度和重度。轻度部分在 2022 年占据最大市场份额,预计在预测期(2022-2030 年)实现最高复合年增长率。全球糖尿病足溃疡市场按最终用户细分为门诊手术中心、医院和家庭护理。医院部分在 2022 年占据最大市场份额,预计在 2022 年至 2030 年期间实现最高复合年增长率。
区域分析:
根据地域划分,全球糖尿病足溃疡市场分为五个主要区域:北美、欧洲、亚太、南美和中美以及中东和非洲。2022 年,北美占据全球糖尿病足溃疡市场规模的最大份额。预计 2022 年至 2030 年期间亚太地区的复合年增长率最高。
美国糖尿病足溃疡市场主要受该国糖尿病患病率上升的推动。根据美国足病医学协会的数据,在美国,患有足溃疡的糖尿病患者中,近 14-24% 需要截肢。根据健康创新计划,美国每年约有 200 万人患上糖尿病足溃疡。此外,根据 2022 年 NCBI 发表的一项研究,美国约有 5% 的糖尿病患者会出现足溃疡,1% 的患者最终需要截肢。该地区老年人口的增长也促进了市场的增长。根据美国老龄管理局 (美国卫生与公众服务部) 2022 年发布的报告,2020 年美国 65 岁及以上人口为 5570 万人。老年人占总人口的 17%,即每 6 个美国人中就有 1 个。根据城市研究所 (华盛顿特区智库) 的估计,未来 40 年,美国 65 岁及以上人口的数量将翻一番,到 2040 年将达到 8000 万人。此外,在 2020 年,糖尿病被视为 65 岁及以上成年人的主要慢性病之一。近年来,多家合资企业、计划和合作机构为加速北美糖尿病足溃疡市场的扩张做出了贡献。例如,2020 年,美国六家研究机构启动了由美国国立卫生研究院资助的首个多中心网络,以研究美国的糖尿病足溃疡。此外,加拿大启动了糖尿病足加拿大计划,以预防糖尿病足并发症。因此,糖尿病的高患病率和老年人口的增加将推动该地区的市场增长。
行业发展和未来机遇:
以下列出了全球糖尿病足溃疡市场的主要参与者采取的各种举措:
- 2023 年 1 月,康维泰克宣布推出 ConvaFoam,这是一系列先进的泡沫敷料,旨在满足医疗保健提供者及其患者的需求。ConvaFoam 可用于伤口治疗过程中任何阶段的各种伤口类型,是伤口管理和皮肤保护的简单敷料选择。
- 2023 年 1 月,MiMedx Group Inc 宣布已与郡士有限公司的子公司郡士医疗有限公司 (GUNZE MEDICAL LIMITED)(“郡士医疗”)签订独家分销协议,在日本销售 EPIFIX。郡士医疗是伤口和外科手术领域广泛使用产品的领先分销商,产品包括缝合线和片状产品等生物可吸收设备和材料。
- 2022 年 3 月,康维泰克通过收购 Triad Life Sciences Inc. 进入颇具吸引力的伤口生物制剂领域。该公司开发生物衍生的创新产品,以满足手术伤口、慢性伤口和烧伤方面未满足的临床需求。
- 2022 年 7 月,Smith+Nephew 宣布推出 WOUND COMPASS 临床支持应用程序。这是一款面向医疗保健专业人员的综合数字支持工具,可帮助进行伤口评估和决策,从而减少实践差异。该应用程序有助于提高护士在评估和治疗伤口时的信心,并让专科护士放心,他们的处方得到遵守。
- 2020 年 1 月,康维泰克集团宣布推出新型超吸收敷料 ConvaMax。该产品用于治疗大量渗出伤口,包括腿部溃疡、压疮、糖尿病足溃疡和裂开的手术伤口。
糖尿病足溃疡市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 74.7 亿美元 |
2030 年的市场规模 | 122.4亿美元 |
全球复合年增长率(2022 - 2030 年) | 6.4% |
历史数据 | 2020-2021 |
预测期 | 2023-2030 |
涵盖的领域 | 根据溃疡类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
竞争格局和重点公司:
Convatec Group Plc、3M Co、Coloplast AS、Smith & Nephew Plc、B. Braun SE、Molnlycke Health Care AB、MiMedx Group Inc、URGO MEDICAL Australia Pty Ltd、Medline Industries LP 和 Organogenesis Inc 是糖尿病足溃疡市场的知名企业。这些公司专注于新技术、现有产品的改进和地域扩张,以满足全球日益增长的消费者需求,并增加其专业产品组合的产品范围。
Diabetic Foot Ulcer Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 7.47 Billion |
Market Size by | US$ 12.24 Billion |
Global CAGR | 6.4% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By 溃疡类型(神经性溃疡、缺血性溃疡和神经缺血性溃疡) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Factors such as high prevalence of diabetes and related chronic wounds and surge in geriatric population propel market growth.
The diabetic foot ulcer market has major market players, including Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Molnlycke Health Care AB, MiMedx Group Inc, URGO MEDICAL Australia Pty Ltd, Medline Industries LP, and Organogenesis Inc.
The diabetic foot ulcer market was valued at US$ 7,470.60 million in 2022.
The diabetic foot ulcer market is expected to be valued at US$ 12,242.77 million in 2030.
Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. Diabetic foot ulcer leads to full thickness skin loss on the foot due to neuropathic and/or vascular complications in patients with type 1 or type 2 diabetes mellitus. Diabetic patient who uses insulin are at a higher risk of developing a foot ulcer.
The global diabetic foot ulcer market, by infection severity, is segmented into moderate, mild, and severe. The mild segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030.
The global diabetic foot ulcer market, by ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers. The neuro-ischemic ulcers segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030.
The global diabetic foot ulcer market, by end user, is segmented into ambulatory surgical centers, hospitals, and home care. The hospital segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030.
The global diabetic foot ulcer market, by treatment type, is segmented into advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment held the largest market share in 2022. The biologics segment is anticipated to register the highest CAGR during 2022–2030.
The List of Companies - Diabetic Foot Ulcer Market
- Convatec Group Plc
- 3M Co
- Coloplast AS
- Smith & Nephew Plc
- B. Braun SE
- Molnlycke Health Care AB
- MiMedx Group Inc
- URGO MEDICAL Australia Pty Ltd
- Medline Industries LP
- Organogenesis Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.